COMERICA BANK - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$1,322,724
+55105.5%
44,899
-20.0%
0.01%
-63.2%
Q4 2022$2,396
-99.9%
56,094
-22.1%
0.02%
-29.6%
Q3 2022$3,247,000
+11.3%
72,029
-1.3%
0.03%
+12.5%
Q2 2022$2,918,000
+9.1%
72,984
+3.2%
0.02%
+26.3%
Q1 2022$2,674,000
+25.7%
70,717
+1.3%
0.02%
+18.8%
Q4 2021$2,128,000
-23.9%
69,812
-7.6%
0.02%
-5.9%
Q3 2021$2,798,000
+39.4%
75,555
+12.9%
0.02%
+41.7%
Q2 2021$2,007,000
+5.8%
66,910
-6.6%
0.01%
+9.1%
Q1 2021$1,897,000
+25.9%
71,630
-3.2%
0.01%
+10.0%
Q4 2020$1,507,000
+25.1%
74,003
+0.6%
0.01%
+11.1%
Q3 2020$1,205,000
-19.6%
73,528
+17.3%
0.01%
-25.0%
Q2 2020$1,498,000
+67.0%
62,694
+9.6%
0.01%
+50.0%
Q1 2020$897,000
+26.7%
57,223
+3.9%
0.01%
+60.0%
Q4 2019$708,000
+16.4%
55,064
+0.5%
0.01%0.0%
Q3 2019$608,000
-2.6%
54,769
+1.8%
0.01%0.0%
Q2 2019$624,000
+32.2%
53,825
-0.6%
0.01%
+25.0%
Q1 2019$472,000
+32.2%
54,154
+3.5%
0.00%
+33.3%
Q4 2018$357,000
-6.1%
52,346
-0.4%
0.00%0.0%
Q3 2018$380,000
-18.6%
52,574
-1.0%
0.00%0.0%
Q2 2018$467,000
+25.2%
53,095
+1.2%
0.00%0.0%
Q1 2018$373,000
-25.3%
52,486
+1.9%
0.00%0.0%
Q4 2017$499,000
-32.3%
51,488
-3.0%
0.00%
-40.0%
Q3 2017$737,000
+7.0%
53,054
+10.8%
0.01%0.0%
Q2 2017$689,00047,8620.01%
Other shareholders
CYTOKINETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders